Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

Humacyte Stock

humacyte.comHealthcareFounded: 2004Funding to Date: $440MM

Humacyte is the developer of a biotechnology platform designed to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine.

Learn more about Humacyte IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Humacyte.

Register Today

Team

Management Team

Theodore Lithgow Ph.D

Chief Operating Officer

William Tente

Chief Regulatory Officer

Shannon Dahl Ph.D

Co-Founder

Jeffrey Lawson MD

President & Chief Executive Officer

Carrie Cox

Chairman & Chief Executive Officer

Laura Niklason MD

Co-Founder & Board Member

Jack Harvey

Vice President, Bioprocessing

Douglas Blankenship

Chief Financial Officer

Juliana Blum Ph.D

Co-Founder & Vice President, Business Operations & Tissue Services

Heather Prichard Ph.D

Senior Vice President of Product Development

Board Members

Brady Dougan

Credit Suisse

Laura Niklason MD

Carrie Cox

Max Wallace JD

Dale Sander

Kathleen Sebelius

Robert Anderson MD

Robert Langer Ph.D

Other companies like Humacyte in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Colossal Biosciences

Sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$4.26B

Sector

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Precision Neuroscience

Sector

Frequently Asked Questions